A regional independent drug assessment center in France published a report which shows that none of the four Covid-19 vaccinations that are currently being administered are either effective or safe, because all of them have received an emergency use authorization, but have gone through insufficient clinical testing.
The research team was led by Dr. Catherine Frade, a pharmacist, whose team worked with public data released by the European Medicines Agency (EMA), in relation with the injections released by Pfizer-BioNTech, Moderna, AstraZeneca, and Janssen (Johnson & Johnson). The injections do not have approval based on clinical evidence of safety and efficacy, but on perceived need.
The French center believes that the jabs are all problematic because the manufacturing processes used are new, as are the excipients they contain, which a team of experts from the Cholet public hospital in France say “should be considered as new active substances.”
All of the vaccines are still subject to studies that extend to 2024 and beyond. At this point, very little is known about the long-term effects of the jabs, although we are already seeing some short-term effects in terms of women’s cycles becoming very irregular and painful, people getting blood-clots and in some cases even death.
According to the French center, all four injections were released to administer to the public before “proof of quality for the active substance and the finished product” was verified. What this means, of course, is that every person who takes the vaccines from any of the aforementioned providers, is a human guinea pig participating in a mass pharmaceutical experiment. How these people fare in the future, remains to be seen.
“Prudence would even dictate that, in all countries where these vaccines against COVID-19 have been marketed, all the batches thus ‘released’ should be withdrawn immediately; and that these MAs that have been granted should be suspended, or even canceled, as a matter of urgency until further notice,” the research team say. They also warn that in the future, “variabilities, which impact the very core of the product, could even invalidate any clinical trials conducted.”
ARTICLE SOURCE : TRENDINGPOLITICS.COM